Recurrence of juvenile dermatomyositis 8 years after remission

Ken Muramatsu; Hideyuki Ujiie; Mayumi Yokozeki; Ichiro Tsukinaga; Mai Ito; Takaaki Shikano; Akira Suzuki; Yusuke Tozawa; Ichiro Kobayashi

doi:10.1016/j.jdcr.2016.10.003

Recurrence of juvenile dermatomyositis 8 years after remission

JAAD Case Rep. 2016 Dec 26;3(1):29-32. doi: 10.1016/j.jdcr.2016.10.003. eCollection 2017 Jan.

Authors

Ken Muramatsu¹, Hideyuki Ujiie², Mayumi Yokozeki³, Ichiro Tsukinaga³, Mai Ito⁴, Takaaki Shikano⁴, Akira Suzuki⁵, Yusuke Tozawa⁶, Ichiro Kobayashi⁷

Affiliations

¹ Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan; Department of Dermatology, KKR Sapporo Medical Center, Sapporo, Japan.
² Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
³ Department of Dermatology, KKR Sapporo Medical Center, Sapporo, Japan.
⁴ Center for Pediatric Allergy and Rheumatology, KKR Sapporo Medical Center, Sapporo, Japan.
⁵ Department of Pathology, KKR Sapporo Medical Center, Sapporo, Japan.
⁶ Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
⁷ Center for Pediatric Allergy and Rheumatology, KKR Sapporo Medical Center, Sapporo, Japan; Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

No abstract available

Keywords: CDASI, Cutaneous Dermatomyositis Area and Severity Index; JDM, juvenile dermatomyositis; MTX, methotrexate; PSL, prednisolone; juvenile dermatomyositis; mPSL, methylprednisolone.

Publication types

Case Reports